NCT04631315 - Difluprednate vs. a Prednisolone Acetate - Phenylephrine on Post-operative Inflammation Following Cataract Surgery. | Biotech Hunter

Enrollment

255

Participants

Timeline

Start Date

March 24, 2019

Primary Completion Date

May 24, 2020

Study Completion Date

July 21, 2020

Conditions

Cataract

Interventions

DRUG

Difluprednate Ophthalmic Emulsion 0.05%

1 drop, 2 times a day, starting the day before surgery and continuing for 14 post-surgical days and 1 drop, once a day for the next 2 weeks.

DRUG

Prednisolone Acetate 1% Phenylephrine hydrochloride 0,12% ophthalmic solution

1 drop, 4 times a day, starting the day before surgery and continuing for 14 post-surgical days and 1 drop, twice a day for the next 2 weeks.

Trial Locations (1)

Laboratorios Poen, Ciudad Autonoma de Buenos Aire